OXYGEN DEVELOPMENT: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
OXYGEN DEVELOPMENT
Largest movements
- Stocks and contracts -€9,199
no longer reported in 2025 (was €9,199)
- Cash -€5,916
down €5,916 (-2.2%), from €265,626 to €259,710
mainly Trade debts (-€14,157) and Net result for the year (-€2,078)
- Trade debts -€14,157
down €14,157 (-15.2%), from €92,834 to €78,677
- Services and other goods -€31,847
no longer reported in 2025 (was €31,847)
- Turnover -€19,365
down €19,365 (-61.1%), from €31,686 to €12,321
- Gross operating margin -€891
new in 2025: -€891
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €360,160 | €343,933 | -€16,227 | -4.5% |
| Current assets | 29/58 | €360,160 | €343,933 | -€16,227 | -4.5% |
| Stocks and contracts in progress | 3 | €9,199 | - | -€9,199 | |
| Stocks | 30/36 | €9,199 | - | -€9,199 | |
| Property held for sale | 35 | €9,199 | - | -€9,199 | |
| Amounts receivable within one year | 40/41 | €85,335 | €84,223 | -€1,112 | -1.3% |
| Trade receivables | 40 | €991 | €1,423 | +€432 | +43.6% |
| Other amounts receivable | 41 | €84,344 | €82,800 | -€1,544 | -1.8% |
| Cash at bank and in hand | 54/58 | €265,626 | €259,710 | -€5,916 | -2.2% |
| Total equity and liabilities | 10/49 | €360,160 | €343,933 | -€16,227 | -4.5% |
| Contributions | 10/11 | €200,000 | €200,000 | = | 0.0% |
| Capital | 10 | €200,000 | €200,000 | = | 0.0% |
| Issued capital | 100 | €200,000 | €200,000 | = | 0.0% |
| Reserves | 13 | €20,000 | €20,000 | = | 0.0% |
| Non-distributable reserves | 130/1 | €20,000 | €20,000 | = | 0.0% |
| Legal reserve | 130 | €20,000 | €20,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €47,191 | €45,113 | -€2,078 | -4.4% |
| Amounts payable | 17/49 | €92,969 | €78,820 | -€14,149 | -15.2% |
| Amounts payable within one year | 42/48 | €92,834 | €78,677 | -€14,157 | -15.2% |
| Trade debts | 44 | €92,834 | €78,677 | -€14,157 | -15.2% |
| Suppliers | 440/4 | €92,834 | €78,677 | -€14,157 | -15.2% |
| Accrued charges and deferred income | 492/3 | €135 | €143 | +€8 | +5.9% |
| Operating income | 70/76A | €31,686 | - | -€31,686 | |
| Turnover | 70 | €31,686 | €12,321 | -€19,365 | -61.1% |
| Operating charges | 60/66A | €32,106 | - | -€32,106 | |
| Goods, raw materials, services and sundry goods | 60/61 | - | €13,212 | +€13,212 | |
| Services and other goods | 61 | €31,847 | - | -€31,847 | |
| Other operating charges | 640/8 | €259 | €277 | +€18 | +6.9% |
| Gross operating margin | 9900 | - | -€891 | -€891 | |
| Operating profit (loss) | 9901 | -€420 | -€1,168 | -€748 | -178% |
| Financial charges | 65/66B | €812 | €910 | +€98 | +12.1% |
| Recurring financial charges | 65 | €812 | €910 | +€98 | +12.1% |
| Debt charges | 650 | €812 | - | -€812 | |
| Profit (loss) for the period before taxes | 9903 | -€1,232 | -€2,078 | -€846 | -68.7% |
| Profit (loss) for the period | 9904 | -€1,232 | -€2,078 | -€846 | -68.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€1,232 | -€2,078 | -€846 | -68.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.